Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial
Anita K M Zaidi, Shiyam Sundar Tikmani, Shazia Sultana, Benazir Baloch, Momin Kazi, Hamidur Rehman, Khairunnissa Karimi, Fyezah Jehan, Imran Ahmed, Simon Cousens, Anita K M Zaidi, Shiyam Sundar Tikmani, Shazia Sultana, Benazir Baloch, Momin Kazi, Hamidur Rehman, Khairunnissa Karimi, Fyezah Jehan, Imran Ahmed, Simon Cousens
Abstract
Background: Infection in young infants is a major cause of morbidity and mortality in low-middle income countries, with high neonatal mortality rates. Timely case management is lifesaving, but the current standard of hospitalization for parenteral antibiotic therapy is not always feasible. Alternative, simpler antibiotic regimens that could be used in outpatient settings have the potential to save thousands of lives.
Methods: This trial aims to determine whether 2 simplified antibiotic regimens are equivalent to the reference therapy with 7 days of once-daily (OD) intramuscular (IM) procaine penicillin and gentamicin for outpatient management of young infants with clinically presumed systemic bacterial infection treated in primary health-care clinics in 5 communities in Karachi, Pakistan. The reference regimen is close to the current recommendation of the hospital-based intravenous ampicillin and gentamicin therapy for neonatal sepsis. The 2 comparison arms are (1) IM gentamicin OD and oral amoxicillin twice daily for 7 days; and (2) IM penicillin and gentamicin OD for 2 days, followed by oral amoxicillin twice daily for 5 days; 2250 "evaluable" infants will be enrolled. The primary outcome of this trial is treatment failure (death, deterioration or lack of improvement) within 7 days of enrollment. Results are expected by early 2014.
Discussion: This trial will determine whether simplified antibiotic regimens with fewer injections in combination with high-dose amoxicillin are equivalent to 7 days of IM procaine penicillin and gentamicin in young infants with clinical severe infection. Results will have program and policy implications in countries with limited access to hospital care and high burden of neonatal deaths.
Trial registration: ClinicalTrials.gov NCT01027429.
Figures
References
- Lawn JE, Cousens S, Darmstadt GL, et al. Why are 4 million newborn babies dying every year? Lancet. 2004;364:2020.
- Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161.
- Darmstadt GL, Black RE, Santosham M. Research priorities and postpartum care strategies for the prevention and optimal management of neonatal infections in less developed countries. Pediatr Infect Dis J. 2000;19:739–750.
- Zaidi AK, Huskins WC, Thaver D, et al. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–1188.
- World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Illnesses with Limited Resources. Geneva, Switzerland: World Health Organization; 2005.
- Owais A, Sultana S, Stein AD, et al. Why do families of sick newborns accept hospital care? A community-based cohort study in Karachi, Pakistan. J Perinatol. 2011;31:586–592.
- Bang AT, Bang RA, Baitule SB, et al. Effect of home-based neonatal care and management of sepsis on neonatal mortality: Field trial in rural India. Lancet. 1999;354:1955–1961.
- Baqui AH, El-Arifeen S, Darmstadt GL, et al. Projahnmo Study Group. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: A cluster-randomised controlled trial. Lancet. 2008;371:1936–1944.
- Zaidi AK, Tikmani SS, Warraich HJ, et al. Community-based treatment of serious bacterial infections in newborns and young infants: A randomized controlled trial assessing three antibiotic regimens. Pediatr Infect Dis J. 2012;31:667–672.
- Sazawal S, Black RE Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: A meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
- Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health. 2011;11(suppl 3):S13.
- Group YICSS. Clinical signs that predict severe illness in children under age 2 months: A multicentre study. Lancet. 2008;12:8.
- Darmstadt GL, Batra M, Zaidi AK. Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings. Pediatr Infect Dis J. 2009;28(1 suppl):S37–S42.
- Hale KA, Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev. 2006;7:145–151.
- Baqui A, et al. Safety and efficacy of simplified antibiotic regimens for outpatient treatment of clinical serious infection among neonates and young infants aged 0–59 days in Bangladesh: Design of a randomized controlled trial. Pediatr Infect Dis J. 2013;32(suppl):S12–S18.
- Qazi S. Simplified regimens for management of neonates and young infants with clinical severe infection in situations when hospital admission is not possible: Study protocol for a randomized, open-label equivalence trial. Pediatr Infect Dis J. 2013;32(suppl):S19–S25.
- Zaidi AK. Scientific rationale for study design of community-based simplified antibiotic therapy trials in newborns and young infants with clinically diagnosed severe infections or fast breathing in South Asia and sub-Saharan Africa. Pediatr Infect Dis J. 2013;32(suppl):S7–S11.
Source: PubMed